NICE nixes Bristol's arthritis med for NHS use - FiercePharma
Links shared publicly online about this topic.
- 401total visits
NICE nixes Bristol's arthritis med for NHS use - FiercePharma
View full resource at fiercepharma.com
Tags: Arthritis, Arthritis Medication, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Drug, Healthcare, Bristol-Myers Squibb
Most Recently Shared on March 30, 2011 at 3:31 pm By:
NICE nixes Bristol's arthritis med for NHS use. http://bit.ly/f46aa5
Yervoy (ipilimumab) Turned Down By UK Watchdog
medicalnewstoday.com — “The National Institute for Clinical Excellence (NICE) has recommended in a draft guidance against Bristol-Myers Squibb's Yervoy (ipilimumab) for the treatment of advanced malignant melanoma in pat” View full resource at medicalnewstoday.com
Most Recently Shared on October 15, 2011 at 3:05 am By:
Yervoy (ipilimumab) Turned Down By UK Watchdog http://t.co/tPKZbrK4 #skincancer #melanoma
Article > NICE final "no" for BM-S' Orencia in RA
pharmatimes.com — “Article > NICE final "no" for BM-S' Orencia in RA” View full resource at pharmatimes.com
Most Recently Shared on August 25, 2011 at 12:30 pm By:
Bristol-Myers Squibb's RA drug Orencia got the final thumbs down from U.K. cost-effectiveness agency. http://t.co/JFs85MD $BMY
NICE says no to BMS for second-line Orencia | InPharm
inpharm.com — “In final draft guidance NICE has not recommended the use of Bristol-Myers Squibb’s arthritis drug Orencia after other drugs have failed” View full resource at inpharm.com
Most Recently Shared on August 25, 2011 at 11:35 am By:
Pharmafocus Pharma and Health News
NICE says no to BMS for second-line Orencia http://ow.ly/6cnhz #nice #arthritis
UK cost agency needs more data on anti-clot drug | Reuters
reuters.com — “* NICE wants more information on Boehringer's Pradaxa * Drug is rival to Bayer's Xarelto, Bristol's Eliquis LONDON, Aug 17 (Reuters) - Britain's healthcarecost-effectiveness watchdog has demanded” View full resource at reuters.com
Most Recently Shared on August 17, 2011 at 12:22 pm By:
A wrench in Boehringer's Pradaxa plans? NICE raises questions about cost-effectiveness of new clot drug. http://t.co/hXYs1Al
Will Novartis, BMS offer NICE a deal on leukemia meds? - FiercePharma
fiercepharma.com — “The U.K.'s cost-effectiveness watchdog certainly doesn't shy away from controversy. The National Institute for Health and Clinical Excellence has moved to limit the use of Novartis and Bristol-Myers Read more...” View full resource at fiercepharma.com
Most Recently Shared on May 6, 2011 at 2:27 pm By:
Will Novartis, BMS offer NICE a deal on leukemia meds? http://bit.ly/izvdo8
New ACOG Opinion on Home Birth Touts Rights, Nixes HBAC and CPMs - The Unnecesarean -
theunnecesarean.com — “New ACOG Opinion on Home Birth Touts Rights, Nixes HBAC and CPMs - The Unnecesarean -” View full resource at theunnecesarean.com
Most Recently Shared on April 30, 2011 at 3:13 am By:
Well, it's nice they recognized the right of a woman to make a decision about where to birth.. but to nix HBAC and... http://fb.me/AjfTBBLb
Draft NICE Guidance Does Not Recommend Abatacept For Second-line Use In Rheumatoid Arthritis
medicalnewstoday.com — “The National Institute for Health and Clinical Excellence (NICE) has today (30 March 2011) opened a consultation on draft guidance which does not recommend abatacept (Orencia, Bristol-Myers Squibb” View full resource at medicalnewstoday.com
Most Recently Shared on March 31, 2011 at 2:56 am By:
Draft NICE Guidance Does Not Recommend Abatacept For Second-line Use In Rheumatoid Arthritis: The National Insti... http://bit.ly/dZu1fo
UK's cost agency rebuffs Bristol arthritis drug | Reuters
reuters.com — “LONDON (Reuters) - Britain's healthcare cost watchdog NICE has recommended against using Bristol-Myers Squibb's rheumatoid arthritis drug Orencia on the state health service as a second-line treatment.The” View full resource at reuters.com
Most Recently Shared on March 30, 2011 at 9:26 pm By:
UK's cost agency rebuffs Bristol arthritis drug http://reut.rs/hEmclt
NICE Recommends Aripiprazole For Schizophrenia In Young People
medicalnewstoday.com — “In final guidance published today, 26 January, NICE has recommended aripiprazole (Abilify, Bristol-Myers Squibb and Otsuka Pharmaceuticals) as an option for the treatment of schizophrenia in peopl” View full resource at medicalnewstoday.com
Most Recently Shared on January 26, 2011 at 6:05 pm By:
NICE Recommends Aripiprazole For Schizophrenia In Young People http://mnt.to/3Qts #mentalhealth
Alternative Treats for Halloween - myOptumHealth
myoptumhealth.com — “You're thinking about nixing the candy this year. Will you be the nerd of the neighborhood if you pass out cool stickers instead of sweets?” View full resource at myoptumhealth.com
Most Recently Shared on October 22, 2010 at 1:37 am By:
jonny bowden Health Professional
8 alternatives to candy for Halloween-- nice article! http://ow.ly/2XtPU
NICE Draft Nixes Golimumab for Psoriatic Arthritis : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on October 6, 2010 at 4:14 pm By:
Skin & Allergy News Health News
NICE Draft Nixes #Golimumab for #Psoriatic Arthritis, reported by Jennie Smith for SAN: http://bit.ly/9LvSIO
NICE Requests More Data On Aripiprazole For Schizophrenia - QualityPoint Technologies
qualitypointtech.net — “In draft guidance , published today (10 September 2010), NICE has asked Bristol-Myers Squibb and Otsuka Pharmaceuticals to provide more data on the effectiveness of their product, aripiprazole (Abilify), as a treatment for schizophrenia in people aged 15 to 17 years. This draft guidance has been issued for consultation and the manufacturer now has an opportunity to respond to the independent Appraisal Committee's considerations and requests...” View full resource at qualitypointtech.net
Most Recently Shared on September 11, 2010 at 5:12 am By:
NICE Requests More Data On Aripiprazole For Schizophrenia: In draft guidance , published today (10 September 2010)... http://bit.ly/cp0fpF
NICE Requests More Data On Aripiprazole For Schizophrenia
medicalnewstoday.com — “In draft guidance , published today (10 September 2010), NICE has asked Bristol-Myers” View full resource at medicalnewstoday.com
Most Recently Shared on September 10, 2010 at 6:00 pm By:
NICE Requests More Data On Aripiprazole For Schizophrenia http://mnt.to/3JBh #schizophrenia
UK's NICE wants more data on schizophrenia drug - QualityPoint Technologies
qualitypointtech.net — “LONDON (Reuters) - Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness. (Source: Reuters: Health)” View full resource at qualitypointtech.net
Most Recently Shared on September 10, 2010 at 4:36 pm By:
UK's NICE wants more data on schizophrenia drug: LONDON (Reuters) - Britain's healthcare cost watchdog said it w... http://bit.ly/d8QfPH
Advertisement
